1. Home
  2. KALA vs NSYS Comparison

KALA vs NSYS Comparison

Compare KALA & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • NSYS
  • Stock Information
  • Founded
  • KALA 2009
  • NSYS 1981
  • Country
  • KALA United States
  • NSYS United States
  • Employees
  • KALA N/A
  • NSYS 775
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • NSYS Industrial Machinery/Components
  • Sector
  • KALA Health Care
  • NSYS Technology
  • Exchange
  • KALA Nasdaq
  • NSYS Nasdaq
  • Market Cap
  • KALA 32.0M
  • NSYS 28.6M
  • IPO Year
  • KALA 2017
  • NSYS N/A
  • Fundamental
  • Price
  • KALA $6.48
  • NSYS $10.12
  • Analyst Decision
  • KALA Strong Buy
  • NSYS
  • Analyst Count
  • KALA 2
  • NSYS 0
  • Target Price
  • KALA $15.00
  • NSYS N/A
  • AVG Volume (30 Days)
  • KALA 33.2K
  • NSYS 5.2K
  • Earning Date
  • KALA 11-12-2024
  • NSYS 11-07-2024
  • Dividend Yield
  • KALA N/A
  • NSYS N/A
  • EPS Growth
  • KALA N/A
  • NSYS 109.80
  • EPS
  • KALA N/A
  • NSYS 1.55
  • Revenue
  • KALA N/A
  • NSYS $135,567,000.00
  • Revenue This Year
  • KALA N/A
  • NSYS N/A
  • Revenue Next Year
  • KALA N/A
  • NSYS N/A
  • P/E Ratio
  • KALA N/A
  • NSYS $6.51
  • Revenue Growth
  • KALA N/A
  • NSYS N/A
  • 52 Week Low
  • KALA $4.21
  • NSYS $8.60
  • 52 Week High
  • KALA $10.97
  • NSYS $19.15
  • Technical
  • Relative Strength Index (RSI)
  • KALA 49.93
  • NSYS 41.91
  • Support Level
  • KALA $6.00
  • NSYS $9.53
  • Resistance Level
  • KALA $7.85
  • NSYS $10.51
  • Average True Range (ATR)
  • KALA 0.40
  • NSYS 0.55
  • MACD
  • KALA -0.11
  • NSYS -0.02
  • Stochastic Oscillator
  • KALA 29.19
  • NSYS 37.00

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.

Share on Social Networks: